FutureNeuro

SFI Research Centre for Chronic and Rare Neurological Diseases

Addressing Neurological Diseases

One in every four people in Ireland are living with a neurological condition. That’s over 1.1 million people, which is costing our economy over €3 billion euro per year. Our system for diagnosing, treating and supporting people with neurological diseases is inadequate. 

FutureNeuro is the SFI Research Centre for Chronic and Rare Neurological Diseases. In partnership with the national clinical network for neurology, our centre contributes to improving the health and health-care of people with neurological disease. Our unique approach is to explore multiple related aspects of brain disease across the themes of diagnostics, therapeutics and eHealth. We are passionate about patient-centred care, backed up by evidence-based research.

Who are we?

Hosted by RCSI, our researchers are based in six others Irish academic institutions: Trinity College Dublin, DCU, UCD, NUI Galway, UCC and WIT. Working with these top national and international research teams in neurology we are making significant scientific discoveries, which will lead to earlier detection, more precise treatment and patient-empowered care pathways.

Congenica Logo

Congenica Logo

Congenica Logo

Congenica Logo

Congenica Logo

Congenica Logo

Congenica Logo

How do we work?

We raise the profile of Irish research. We are training a team of highly-qualified researchers who will work in hospital, research and industry settings. We generate exchequer value by winning valuable EU research programmes and working collaboratively with industry partners to bring a pipeline of new diagnostic, therapeutic and eHealth solutions to market.

Diagnostics

Our Diagnostics research looks at applying sequencing and advanced informatics and nanomaterials technology to discover, detect and interpret biomolecules from patients collected via national clinical networks to deliver faster, more accurate diagnosis.

Therapeutics

Our Therapeutics research is exploring new types of therapies,  including molecules that work by controlling the activity of networks of genes to stabilize or recover brain function to see how we could deliver these to the brain. 

eHealth

Our eHealth research aims to deliver a research-adapted continuously learning and innovative healthcare system through careful design, development and implementation of eHealth technologies.

What do we do?

Epilepsy Research

Our epilepsy research focuses on the causes, diagnosis and treatment of epilepsy. In particular, understanding genetic contributions to epilepsy and drug response, on the identification of molecular, imaging and electrophysiological biomarkers of epilepsy, and driving next-generation therapeutics development that use advanced molecular designs to adjust brain function to reduce hyperexcitability and stop seizures.

 

 

 

 

 

 

 

 

 

 

 

 

Multiple Sclerosis Research

Our research is a combination of preclinical and clinical discovery. We focus on understanding the impact of the immune system in Multiple Sclerosis, with the aim to understand how manipulation of microRNAs and metabolic pathways in macrophages may be therapeutically harnessed for the treatment of MS. We also investigate the prevalence and nature of cognitive impairment, using state of the art neurophysiologic technologies with to a view to improving clinical trials and resulting therapies.

 

 

 

 

Rare Paediatric Diseases

We have multiple projects focused on rare neurodevelopmental disorders. This includes Angelman, Dravet and Rett syndromes. Each are characterized by mutations in critical genes for brain development and function and share in common serious drug-resistant epilepsy as well as other life-limiting disabilities. Our preclinical and clinical research is exploring the underlying mechanisms of the diseases, identifying potential biomarkers and developing innovative new therapeutics including gene therapy approaches.

 

 

 

 

 

 

 

 

 

 

Motor Neurone Disease Research

Our ALS research explores genetic variants and stem cell modelling to inform disease diagnostics along with the integration of clinical phenotype to develop more precise stratification tools for clinical trials.

 

 

 

 

 

 

 

 

 

Parkinson's Research

Our Parkinson’s research harnesses our expertise in neuronal physiology, systems modelling, bioinformatics, neuronal physiology and mitochondrial bioenergetics to investigate the role of mitochondrial dysfunction in Parkinson’s disease

 

 

 

 

 

 

 

 

 

 

 

 

 

Scientific Breakthroughs

We have already made substantial scientific breakthroughs.   Our research has been published in top journals including  Nature Communications, Journal of Clinical Investigation and JAMA Neurology. We have achieved scientific breakthroughs and major advances in all three Thematic areas of the Centre.

 

Breakthrough 1

New molecules discovered in blood samples from patients with epilepsy may support diagnosis and/or predict when a seizure may occur

Breakthrough 2

Resolving the genetics of epilepsy, predicting drug side effects and population structure in Scotland and Ireland.

Breakthrough 3

New human cell models of ALS

Breakthrough 4

New microRNA targets for epilepsy and rare neurodevelopmental disorders

Breakthrough 5

World’s first integrated genomics module in an epilepsy-specific electronic patient record

Public Patient Involvement

The patient and their family is at the centre of our research. Our Engaged Research approach aims to include people with neurological diseases in the design and delivery of our research. Our communications and outreach programme involving all of our researchers and clinicians aims to address the stigma of neurological disease.

Join Us! Opportunity to Design Digital Health Study

Opportunity to design a digital health study and apply for PhD funding We are seeking a self-motivated and forward thinking individual who is interested in pursuing a PhD in the area of digital health and would like to join the RCSI University of Medicine and Health...

Getting to Know Our FutureNeuro Team: PhD Student Kelvin Lau E How

'Needless to say that the most favourite thing about my job is the opportunity to work with brilliant scientists within the group. This opportunity doesn’t come often, and I am fortunate enough to be a part of a scientific programme that is going to revolutionize how...

FutureNeuro Science Week Diary 2021

Another Science Week is upon us and we are excited to host a variety of different events across the week. Do join us! Tuesday 9th Nov- New Frontiers at the Intersection of Data Science and Neurology- Exploring how how data analytics, A.I. and deep learning algorithms...

NeuroInsight Seeks 15 researchers to Start 2-year Fellowship

NeuroInsight is a Marie-Sklodowska Curie Fellowships programme. The programme aims to support a new kind of postdoc-level researcher, who will develop advanced skills in data analytics, AI, machine and deep learning and apply them to the challenges of neurological...

Minister Simon Harris Launches Empower; Data Governance Programme

  Minister Simon Harris Launches Empower; Data Governance Programme The Empower programme ‘opens the door of opportunity’ for FutureNeuro to drive innovation in health-care while safe-guarding the interests of patients and their data. FutureNeuro, the SFI...

Latest News

Read the most up-to-date information about our projects, public engagement, industry partners, public patient involvement activities and our media articles.

Industry Partners

Congenica Logo
Congenica Logo
Congenica Logo
Congenica Logo
Congenica Logo
Congenica Logo
Congenica Logo
Congenica Logo
Congenica Logo
Congenica Logo
Eisai Logo
Congenica Logo
Congenica Logo
Congenica Logo
Congenica Logo
Skip to content